Last updated: March 20, 2024
Sponsor: Nantes University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Reproductive Health
Vaginal Infection
Gynecological Infections
Treatment
laparoscopy
ultrasound transvaginal drainage
Clinical Study ID
NCT05408624
RC21_0011
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Major patient at the time of inclusion
- Patient with diagnosis of TOA with a latero-uterine mass measuring at least 3 cm
Exclusion
Exclusion Criteria:
- Patient with severity criteria requiring hospitalization:
- Clinical severity criteria: haemodynamically unstable patient, septic shock,defense or contracture, sepsis, pelviperitonitis
- Comorbidities: diabetic imbalance, curative anticoagulation
- Patient with a formal indication for laparoscopy:
- Diagnostic doubt with suspicion of an associated oncological or digestivepathology
- Presence of an intra-abdominal intrauterine device (IUD)
- Abscess not accessible vaginally
- Patient who does not meet the eligibility criteria for outpatient hospitalizationdefined by French High Autority of Health
- Patient under guardianship or curatorship
- Patient does not speak French
- Patient not benefiting from social security coverage
- Current pregnancy
- Confirmed allergy to one of the antibiotics (ceftriaxone, metronidazole ordoxycycline)
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: laparoscopy
Phase:
Study Start date:
July 15, 2022
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
CHU Nantes
Nantes,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.